SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-19-174714
Filing Date
2019-06-17
Accepted
2019-06-17 16:02:05
Documents
12
Period of Report
2019-07-31
Effectiveness Date
2019-06-17

Document Format Files

Seq Description Document Type Size
1 DEF 14A d762678ddef14a.htm DEF 14A 426696
2 GRAPHIC g762678g36a41.jpg GRAPHIC 1676
3 GRAPHIC g762678g40v16.jpg GRAPHIC 33741
4 GRAPHIC g762678g45i70.jpg GRAPHIC 210974
5 GRAPHIC g762678g45k90.jpg GRAPHIC 18137
6 GRAPHIC g762678g45m02.jpg GRAPHIC 38731
7 GRAPHIC g762678g45p54.jpg GRAPHIC 14501
8 GRAPHIC g762678g46a05.jpg GRAPHIC 11556
9 GRAPHIC g762678g46p93.jpg GRAPHIC 24185
10 GRAPHIC g762678g46r17.jpg GRAPHIC 12231
11 GRAPHIC g762678g62c08.jpg GRAPHIC 14521
12 GRAPHIC g762678g90m52.jpg GRAPHIC 15266
  Complete submission text file 0001193125-19-174714.txt   967091
Mailing Address 1035 O'BRIEN DRIVE MENLO PARK CA 94025
Business Address 1035 O'BRIEN DRIVE MENLO PARK CA 94025 650-272-6269
Adverum Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36579 | Film No.: 19901432
SIC: 2836 Biological Products, (No Diagnostic Substances)